At PharmAsia Summit, VCs Discuss Financing Innovation in Asia
This article was originally published in The Pink Sheet Daily
Executive Summary
As returns falter in the U.S., VC firms are finding that infrastructure investments overseas are opening up uncharted territory for the life sciences industry.